Amogh Verma, Divij Sharma, Manu Pant, Mahalaqua Na. First sighting of human H5N1 in Australia: A detailed account and public health implications. New Microbes and New Infections, Vol 60–61, 2024,1
On May 22, 2024, Australia reported its first confirmed case of human infection with avian influenza A(H5N1) virus to the World Health Organization (WHO). This incident marked a significant development in the epidemiological landscape of Australia, highlighting the nation´s public health challenges and response mechanisms. This case also highlights the broader context of H5N1´s global spread, with earlier cases reported in the United States and Vietnam in 2024.
The notification came from Australia´s International Health Regulations (IHR) National Focal Point (NFP). This case involved a 2.5-year-old female child with no underlying health conditions. The child had a history of travel to Kolkata, India, from February 12 to February 29, 2024, and had returned to Australia on March 1, 2024. Upon her return, she was admitted to a hospital in Victoria on March 2, 2024, because of symptoms. On March 4, she was transferred to the intensive care unit of a referral hospital in Melbourne because of worsening symptoms. The patient was discharged after a 2.5-week hospital stay and is now clinically well. The WHO Collaborating Centre (WHO CC) for Reference and Research on Influenza in Australia initially notified the NFP of a suspected case on May 17, 2024. The H5N1 infection was confirmed by the Victorian Department of Health on May 18, 2024. Subsequently, the NFP of Australia informed the NFP of India about the confirmed case on May 21, 2024, and WHO was notified the following day.
The notification came from Australia´s International Health Regulations (IHR) National Focal Point (NFP). This case involved a 2.5-year-old female child with no underlying health conditions. The child had a history of travel to Kolkata, India, from February 12 to February 29, 2024, and had returned to Australia on March 1, 2024. Upon her return, she was admitted to a hospital in Victoria on March 2, 2024, because of symptoms. On March 4, she was transferred to the intensive care unit of a referral hospital in Melbourne because of worsening symptoms. The patient was discharged after a 2.5-week hospital stay and is now clinically well. The WHO Collaborating Centre (WHO CC) for Reference and Research on Influenza in Australia initially notified the NFP of a suspected case on May 17, 2024. The H5N1 infection was confirmed by the Victorian Department of Health on May 18, 2024. Subsequently, the NFP of Australia informed the NFP of India about the confirmed case on May 21, 2024, and WHO was notified the following day.
See Also:
Latest articles in those days:
- Emergence of a genetically distinct cluster of influenza A(H3N2) viruses within subclade J.2.2 associated with hospitalization during the 2024-2025 season in Auvergne-Rh?ne-Alpes, France 8 hours ago
- Interaction between DEAD-box RNA helicase 10 and influenza PB1 polymerase selectively regulates influenza A virus replication 8 hours ago
- Genetic Diversity of Clade 2.3.4.4b H5Nx High Pathogenicity Avian Influenza Viruses Detected in Korea During the 2025-2026 Winter Season and Pathogenicity of H5N1 and H5N9 Viruses 8 hours ago
- Update and optimization of a multiplex RT-qPCR assay to overcome diagnostic failure in emerging influenza A(H3N2) subclades J.2 and K (Peru, 2024-2026) 8 hours ago
- Antigenic and structural analysis of the influenza hemagglutinin lateral patch 8 hours ago
[Go Top] [Close Window]


